Rentschler Biopharma Completes Acquisition of US Manufacturing Site

Date Published01/03/2019
Author NameBioPharm International Editors
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Rentschler Biopharma
Parent companyRentschler Biopharma
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):70
Year reshoring announced:2019
Country(ies) from which reshored:Germany
City reshored to:Milford
State(s) reshored to:MA
If relevant, work nearshored to:-
What domestic positive factors made reshoring more attractive?Customer responsiveness improvement, Eco-system synergies, Proximity to customers/market, Under-utilized capacity
Find Reshoring Articles